SCHEMBL8668708

SCHEMBL8668708

CCCC(Cl)C(=O)N(Cc1ccc(Cl)cc1Cl)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.43
TP53 P04637 2/20 0.41
AGTR2 P50052 1/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CYP3A4 P08684 1/20 0.40
LMNA P02545 1/20 0.40
SLC6A2 P23975 5/20 0.40
SLC6A4 P31645 5/20 0.40
CYP2D6 P10635 1/20 0.39
KCNH2 Q12809 1/20 0.39
LTB4R2 Q9NPC1 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PSEN1 P49768 1/20 0.39
PSEN2 P49810 1/20 0.39
APH1B Q8WW43 1/20 0.39
NCSTN Q92542 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10984012 0.78 ALDH1A1 (0.47) TSHRTP53ATML3MBTL1CYP3A4
SCHEMBL9297344 0.72 TP53 (0.44) TSHRTP53ATML3MBTL1CYP3A4
SCHEMBL10987013 0.70 NPC1 (0.51) TSHRTP53ATML3MBTL1CYP3A4
SCHEMBL10672713 0.69 SLC6A2 (0.46) L3MBTL1CYP3A4SLC6A2SLC6A4CYP2D6
SCHEMBL11003393 0.69 PYCR1 (0.51) TP53ATML3MBTL1CYP3A4LMNA
SCHEMBL11173418 0.68 IDO1 (0.47) TP53CYP3A4LMNASLC6A2SLC6A4
SCHEMBL3065407 0.68 NOS3 (0.54) TSHRTP53CYP3A4
SCHEMBL5644342 0.66 SLC6A2 (0.55) ATMSLC6A2SLC6A4
SCHEMBL27665039 0.66 TP53 (0.43) TSHRTP53AGTR2ATML3MBTL1
SCHEMBL11875302 0.66 TAS1R3 (0.35) TP53CYP3A4LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5834514-A INHIBITORS OF INTERLEUKIN-1B CONVERTING ENZYME, TREATMENT OF INFLAMMATORY AND IMMUNE BASED DISEASES OF THE LUNGS, CENTRAL NERVOUS SYSTEM AND CONNECTIVE TISSUES VERTEX PHARMACEUTICALS, INCORPORATED (US) 1998-11-10 US claimed